Observations on the evolution and treatment of idiopathic infantile hypercalcemia

Goodyer, PR; Frank, A; Kaplan, BS

HERO ID

4120689

Reference Type

Journal Article

Year

1984

Language

English

PMID

6502307

HERO ID 4120689
In Press No
Year 1984
Title Observations on the evolution and treatment of idiopathic infantile hypercalcemia
Authors Goodyer, PR; Frank, A; Kaplan, BS
Journal Journal of Pediatrics
Volume Pediatr
Issue REF 10
Page Numbers 771-773
Abstract IPA COPYRIGHT: ASHP The case of an infant who developed idiopathic infantile hypercalcemia in the postnatal period while receiving breast milk and calcium gluconate supplements is reported. The mother was taking ergocalciferol (vitamin D2) supplements (400 U/day) since early in pregnancy. Breast feeding was continued but all vitamin D supplements were stopped and the infant was given prednisone (0.5 mg/kg; I) 2 times/day. The serum calcium concentration decreased from 17.6 to 13.6 mg/dl. In an attempt to promote growth I therapy was reduced and 5 units of thyrocalcitonin (Calcimar; calcitonin; II) was injected SC each morning and 0.5 g cellulose sodium phosphate (Calcibind; III) was given orally 5 times a day before feeding. It was concluded that daily II injection to reduce ongoing flux of calcium from the bone to blood and III to reduce absorption of dietary calcium may be successful in maintaining normocalcemia while permitting discontinuation of I.
Pmid 6502307
Is Certified Translation No
Dupe Override No
Is Public Yes
Language Text English